Top Markets
#1 ADO Protocol ADO Protocol +233.73%
#2 Islamic Coin Islamic Coin +155.42%
#3 GoPlus Security GoPlus Security +60.87%
#4 Verus Coin Verus Coin +33.01%
#5 Starpower Starpower +28.54%
#6 GAIB AID GAIB AID +24.67%
#7 Casper Network Casper Network +16.10%
#8 o1.exchange o1.exchange +13.60%
#9 Status Status +11.71%
#10 Lumia Lumia +11.38%
Coin of the day
ADO Protocol ADO Protocol
Instellingen
Taal
DUTCH
Valuta
USD
Thema
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Rang in aandelen #33734
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Aandeelprijs
$4.58
Laatst gesynchroniseerd: 2025-05-09
Marktkapitalisatie
$6.98M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel NeuroMetrix, Inc. (NURO)

Categorie

Healthcare
P/S-ratio voor NeuroMetrix, Inc. (NURO)
P/S-ratio op August 2026 TTM: 3.11
Volgens de meest recente financiële rapporten en aandelenkoers van NeuroMetrix, Inc. is de huidige P/S-ratio (TTM) 3.11. Eind 2023 had het bedrijf een P/S-ratio van 0.64.
P/S-ratiohistoriek voor NeuroMetrix, Inc. van 2001 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
2026 (TTM) 3.11 20.56%
2024 2.58 305.89%
2023 0.64 -50.63%
2022 1.29 -89.69%
2021 12.48 -3.81%
2020 12.98 194.44%
2019 4.41 54.39%
2018 2.85 107.21%
2017 1.38 -58.19%
2016 3.30 -62.48%
2015 8.78 -61.93%
2014 23.07 -12.31%
2013 26.31 351.05%
2012 5.83 57.37%
2011 3.71 -58.86%
2010 9.01 -28.96%
2009 12.68 312.90%
2008 3.07 -85.25%
2007 20.83 -22.83%
2006 26.98 -65.07%
2005 77.26 22.47%
2004 63.09 -22.35%
2003 81.25 -53.91%
2002 176.30 -18.00%
2001 215.00 0.00%
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.13 32.87%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
5.03 61.82%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -10.46%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.67 17.97%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.10 160.38%
US